Ismigen tab. sublingual 7mg # 30
Category
Antiviral
,
Antimicrobial agents
Scope of the medicinal product
The immune system
Release form
Tablet
Manufacturer country
Italy
Package quantity, pcs
thirty
Tablets flat-cylindrical with a scored, light cream color with brown blotches and a faint smell of mint
Pharmaco-therapeutic group
N4 Acute and subacute upper and lower respiratory tract infections: bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis media, including complications after influenza (treatment as part of combination therapy).
Recurrent infections of the upper and lower respiratory tract, chronic bronchitis В¬ (prevention of exacerbations).
Application during pregnancy and during breastfeeding
Contraindicated
Dosage form
Sublingual tablets 7 mg.
10 tablets in a blister strip of polyvinyl chloride film and aluminum foil.
1 or 3 blisters together with instructions for use in a cardboard box.
Shelf life
3 years.
Do not use after the expiration date.
Category
Immunostimulating agent
Name ENG
ISMIGEN
Clinical and pharmacological group
Immunostimulating drug
ATX code
Other immunostimulants
Dosage
7mg
Structure
Lyophilized bacterial lysates - 50 mg, including the active component: lysates of bacteria Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae (types - TY1 ��/ EQ11, TY2 / EQ22, TY3 / EQ14, TY5 / EQ15, TY5 / EY47 / EQ 24), Klebsiella pneumoniae, Klebsiella ozaenae, Haemophilus influenzae b, Neisseria catarrhalis - 7.0 mg excipient: glycine - 43 mg.
Excipients - microcrystalline cellulose 150.0 mg, calcium hydrogen phosphate dihydrate 35.0 mg, colloidal silicon dioxide 10.0 mg, magnesium stearate 3.0 mg, ammonium glycyrrhizinate 1.2 mg, mint flavor 0.8 mg.
Indications
Acute and subacute infections of the upper and lower respiratory tract: bronchitis tonsillitis pharyngitis laryngitis rhinitis sinusitis otitis media, including complications after influenza (treatment in combination therapy). Recurrent infections of the upper and lower respiratory tract, chronic bronchitis (prevention of exacerbations) ...
Contraindications
Hypersensitivity to the active and / or auxiliary components of the drug, autoimmune diseases, pregnancy, breastfeeding, children under 3 years of age.
Storage conditions and periods
Store at a temperature not exceeding 25 В° C.
Keep out of the reach of children.
INN / Active ingredient
Bacterial lysates
Specifications
Category
Antiviral
,
Antimicrobial agents
Scope of the medicinal product
The immune system
Release form
Tablet
Manufacturer country
Italy
Package quantity, pcs
thirty
Scope of application
Pulmonology
,
Immunology
Minimum age from
3 years old
Way of introduction
Under the tongue
Vacation conditions
Without recipe
Brand name
Stada
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Immunostimulating agent
Anatomical and therapeutic characteristics
L03AX Other immunostimulants
Dosage form
Sublingual tablets
Packaging
Cardboard box
The target audience
Adult
Expiration date in days
1095
Package weight, g
thirty
Mode of application
:
Under the tongue take on an empty stomach. The tablet should be kept under the tongue until it is completely dissolved. Sublingual tablets should not be sucked, chewed or swallowed. Acute and subacute infections of the upper and lower respiratory tract 1 tablet per day until the symptoms of the disease disappear (at least 10 days). Recurrent infections of the upper and lower respiratory tract, prevention of exacerbations of chronic respiratory diseases 1 tablet per day for 10 days. The preventive course includes three cycles of 10 days with 20-day intervals between them. The preventive course should be carried out no more than 1-2 times a year. If you skip taking the next dose, you should not double it the next time you take it. If after treatment there is no improvement or the symptoms worsen, or new symptoms appear, you should consult your doctor.Use the drug only according to the indications, the method of administration and the doses indicated in the instructions.
Dosage (volume) of the substance in the preparation
:
bacterial lysates, incl.
Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae (types - TY1 ��/ EQ11, TY2 / EQ22, TY3 / EQ14, TY5 / EQ15, TY8 / EQ23, TY47 / EQ24), Klebsienseella pneumella catarrhalis 7 mg